These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8377010

  • 1. Reduction in glial fibrillary acidic protein mRNA abundance induced by (-)-deprenyl and other monoamine oxidase B inhibitors in C6 glioma cells.
    Li XM, Qi J, Juorio AV, Boulton AA.
    J Neurochem; 1993 Oct; 61(4):1573-6. PubMed ID: 8377010
    [Abstract] [Full Text] [Related]

  • 2. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
    Klegeris A, McGeer PL.
    Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M, Jain S, Baquer NZ.
    Biochem Pharmacol; 1990 Nov 15; 40(10):2215-8. PubMed ID: 2123104
    [Abstract] [Full Text] [Related]

  • 5. Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
    Inaba-Hasegawa K, Akao Y, Maruyama W, Naoi M.
    J Neural Transm (Vienna); 2012 Apr 15; 119(4):405-14. PubMed ID: 22065207
    [Abstract] [Full Text] [Related]

  • 6. L-deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brain.
    Biagini G, Zoli M, Fuxe K, Agnati LF.
    Neuroreport; 1993 Jul 15; 4(7):955-8. PubMed ID: 8369488
    [Abstract] [Full Text] [Related]

  • 7. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J.
    Vopr Med Khim; 1997 Jul 15; 43(6):482-93. PubMed ID: 9503565
    [Abstract] [Full Text] [Related]

  • 8. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 15; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 9. (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase.
    Tatton WG, Wadia JS, Ju WY, Chalmers-Redman RM, Tatton NA.
    J Neural Transm Suppl; 1996 Feb 15; 48():45-59. PubMed ID: 8988461
    [Abstract] [Full Text] [Related]

  • 10. Modulation of glutamate neurotoxicity in the transformed cell culture by monoamine oxidase inhibitors, clorgyline and deprenyl.
    Abakumova OYu, Podobed OV, Tsvetkova TA, Yakusheva IV, Moskvitina TA, Kondakova LI, Navasardyantz DG, Medvedev AE.
    J Neural Transm Suppl; 1998 Feb 15; 52():87-91. PubMed ID: 9564611
    [Abstract] [Full Text] [Related]

  • 11. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K, Szende B.
    Neurotoxicology; 2004 Jan 15; 25(1-2):233-42. PubMed ID: 14697898
    [Abstract] [Full Text] [Related]

  • 12. [Role of R-(-)-deprenyl in adhesion of neuronal and non-neuronal cells].
    Jenei V, Zor K, Magyar K, Jakus J.
    Orv Hetil; 2005 Mar 27; 146(13):601-6. PubMed ID: 15856624
    [Abstract] [Full Text] [Related]

  • 13. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD, Azzaro AJ.
    J Neurochem; 1981 Aug 27; 37(2):527-30. PubMed ID: 6790675
    [Abstract] [Full Text] [Related]

  • 14. Is there a "non-MAO" macromolecular target for L-deprenyl?: Studies on MAOB mutant mice.
    Ekblom J, Oreland L, Chen K, Shih JC.
    Life Sci; 1998 Aug 27; 63(12):PL181-6. PubMed ID: 9749831
    [Abstract] [Full Text] [Related]

  • 15. R-deprenyl: pharmacological spectrum of its activity.
    Magyar K, Szende B, Jenei V, Tábi T, Pálfi M, Szöko E.
    Neurochem Res; 2010 Dec 27; 35(12):1922-32. PubMed ID: 20725780
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T, Satoh S, Satoh N, Kisara K, Arai Y, Kim SK, Kinemuchi H.
    J Pharmacol Exp Ther; 1989 Jul 27; 250(1):254-60. PubMed ID: 2501477
    [Abstract] [Full Text] [Related]

  • 17. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl.
    Robinson JB.
    Biochem Pharmacol; 1985 Dec 01; 34(23):4105-8. PubMed ID: 3933519
    [Abstract] [Full Text] [Related]

  • 18. Specific irreversible monoamine oxidase B inhibitors stimulate gene expression of aromatic L-amino acid decarboxylase in PC12 cells.
    Li XM, Juorio AV, Paterson IA, Zhu MY, Boulton AA.
    J Neurochem; 1992 Dec 01; 59(6):2324-7. PubMed ID: 1431909
    [Abstract] [Full Text] [Related]

  • 19. The molecular pharmacology of L-deprenyl.
    Gerlach M, Riederer P, Youdim MB.
    Eur J Pharmacol; 1992 Jun 05; 226(2):97-108. PubMed ID: 1639115
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological actions of l-deprenyl (selegiline) and other selective monoamine oxidase B inhibitors.
    Youdim MB, Finberg JP.
    Clin Pharmacol Ther; 1994 Dec 05; 56(6 Pt 2):725-33. PubMed ID: 7995014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.